+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages



Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages



American Journal of Pathology 177(3): 1143-1154



Macrophages are heterogeneous and include classically activated M1 and alternatively activated M2 macrophages, characterized by pro- and anti-inflammatory functions, respectively. Macrophages that express heme oxygenase-1 also exhibit anti-inflammatory effects. We assessed the anti-inflammatory effects of statin in experimental anti-glomerular basement membrane glomerulonephritis and in vitro, focusing on the macrophage heterogeneity. Rats were induced anti-glomerular basement membrane glomerulonephritis and treated with atorvastatin (20 mg/kg/day) or vehicle (control). Control rats showed infiltration of macrophages in the glomeruli at day 3 and developed crescentic glomerulonephritis by day 7, together with increased mRNA levels of the M1 macrophage-associated cytokines, interferon-gamma, tumor necrosis factor-alpha, and interleukin-12. In contrast, statin reduced the level of proteinuria, reduced infiltration of macrophages in glomeruli with suppression of monocyte chemotactic protein-1 expression, and inhibited the formation of necrotizing and crescentic lesions. The number of glomerular ED3-positive macrophages decreased with down-regulation of M1 macrophage-associated cytokines. Furthermore, statin augmented ED2-positive M2 macrophages with up-regulation of the M2 macrophage-associated chemokines and cytokines, chemokine (C-C motif) Iigand-17 and interleukin-10. Statin also increased the glomerular interleukin-10-expressing heme oxygenase-1-positive macrophages. Statin inhibited macrophage development, and suppressed ED3-positive macrophages, but augmented ED2-positive macrophages in M2-associated cytokine environment in vitro. We conclude that the anti-inflammatory effects of statin in glomerulonephritis are mediated through inhibition of macrophage infiltration as well as augmentation of anti-inflammatory macrophages.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911057

Download citation: RISBibTeXText

PMID: 20696778

DOI: 10.2353/ajpath.2010.090608


Related references

Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis. Nephrology 23(2): 183-189, 2016

Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Laboratory Investigation; a Journal of Technical Methods and Pathology 65(3): 272-279, 1991

Anti-glomerular basement membrane glomerulonephritis in the mouse: the role of macrophages. International Journal of Experimental Pathology 76(2): 157-162, 1995

ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis. American Journal of Physiology. Renal Physiology 298(4): F870-F882, 2010

Glomerular procoagulant activity in experimental anti glomerular basement membrane antibody induced glomerulonephritis. Kidney International 28(5): 856, 1985

Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effects. Nephrology, Dialysis, Transplantation 2018, 2018

Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis. American Journal of Pathology 170(5): 1485-1496, 2007

Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis. Nephrology, Dialysis, Transplantation 31(4): 574-585, 2017

Experimental induction of glomerulonephritis mediated by anti-glomerular basement membrane and anti-brush border antibodies in a single rat. Acta Pathologica Japonica 32(2): 281-292, 1982

Endogenous glucocorticoids modulate experimental anti-glomerular basement membrane glomerulonephritis. Clinical & Experimental Immunology 119(1): 161-168, 2000

Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. European Journal of Immunology 35(10): 3074-3082, 2005

Endogenous glucocorticoids modulate experimental anti-glomerular basement membrane glomerulonephritis. Clinical and Experimental Immunology 119(1): 161-168, 1999

Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats. International Immunology 16(5): 625-634, 2004

Butein (3,4,2',4'-tetrahydroxychalcone) ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis (3). European Journal of Pharmacology 316(2-3): 297-306, 1996

Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma. Journal of the American Society of Nephrology 15(7): 1764-1774, 2004